ABSTRACT
INTRODUCTION T
HE FIRST CDNA FOR VIRUS-INDUCED chicken interferon (ChIFN) was cloned in 1994. (1) Subsequent work revealed that the chicken uses at least 10 intronless genes to provide IFNa. (2) Low-stringency hybridization screening of a phage library resulted in identification of a distantly related intronless ChIFN gene, (2) now designated IFN-b. ( 3) The IFN-a and IFN-b genes are clustered and map to the tip of the long arm of the chicken Z chromosome. (4) Because polyclonal antisera raised against recombinant IFN-a failed to neutralize the antiviral activity of IFN-b, (2) it was concluded that chickens, like mammals, possess serologically distinct type I IFNs. However, it remained unclear if IFN-b contributes to the antiviral state in chickens because an IFN-a-specific antiserum almost completely neutralized the antiviral activity secreted by either chicken spleen cells in response to concanavalin A (ConA) (5) or chicken embryo cells in response to DNA transfection. (6) Furthermore, birds injected with monoclonal antibody (mAb) 8A9, which specifically neutralizes ChIFN-a, showed enhanced tumor incidence in Rous sarcoma virus-infected chickens. (7) As work with recombinant chicken cytokines indicated that the specific antiviral activity of IFN-b was approximately 10-fold lower than that of IFN-a, (2) it remained unclear whether the magnitude of ChIFN-b synthesis had been underestimated previously.
Recent research interest focuses on the question of why many viruses manage to replicate surprisingly well in the face of a strong innate immune response of the infected hosts. (8) Emerging evidence indicates that most successful viruses, including such pathogens of poultry as Newcastle disease virus (NDV) and influenza A virus, code for proteins that interfere with the IFN system. For example, the NS1 protein of influenza A virus limits IFN production in infected cells presumably by sequestering double-stranded RNA (dsRNA), (9) which would otherwise trigger toll-like receptor-3 (TLR-3) activation and other innate immune responses. The V protein of NDV has a different mode of action against the host IFN response. It limits the action of IFN by blocking IFN-dependent signaling pathways. (10) (11) (12) Pathogenesis studies of these viruses in avian hosts are hampered by incomplete knowledge of the ChIFN system and by a shortage of suitable reagents.
We have developed specific antisera to ChIFN-a and ChIFN-b and set up an alternative bioassay that detects IFN-b with high sensitivity. Our experiments demonstrated that IFNa and IFN-b can both be produced during infection of chicken embryo cells with viruses, such as influenza A virus.
MATERIALS AND METHODS

Recombinant chicken cytokines
Human 293T cells were transiently transfected with cDNA expression constructs (pcDNA vector) (Invitrogen, San Diego, CA) for ChIFN-a, (2) ChIFN-b, (2) ChIFN-g, (5, 13) and N-terminally truncated interleukin-1b (IL-1b) (ATG-80-11-12 (14) ). At 16-20 h after plasmid transfection, the medium was changed. Media containing the various cytokines were harvested 48 h later, and cell debris was removed by centrifugation. Short-term storage of the samples was at 4°C, and long-term storage was at 220°C.
Virus-induced natural ChIFN
Confluent monolayers of cells prepared from 10-day-old chicken embryos were infected with various viruses at a multiplicity of infection (moi) of 5. Viruses used in this study were NDV strain H53, (15) influenza A virus PR8 lacking the NS1 gene (FluA), (9) modified vaccinia virus (VV) Ankara (MVA), (16) Rift valley fever virus strain M19, (17) and the Freiburg variant of Thogotovirus lacking the ability to synthesize the ML protein. (18) At approximately 48 hours post infection, the culture media were harvested. The cell debris was removed by centrifugation, and the supernatants were treated with perchloric acid as described. (19) At the end of the acid treatment procedure, the pH was brought back into the neutral range, the insoluble precipitate was removed by centrifugation, and the cleared supernatants were stored at 4°C. Before use, the supernatants were incubated overnight at 4°C with the indicated amounts of the various antisera.
IFN assays
Antiviral assay. Vesicular stomatitis virus (VSV) was used to challenge cytokine-treated CEC-32 quail cells as described. (16) Nonviral assay. A plasmid in which luciferase gene expression is controlled by a short fragment (position 2216 to 145) of the chicken Mx promoter (20) was transfected into CEC-32 cells, and stably transfected cells were selected. These cells were seeded at approximately 2 3 10 5 cells per well into 24-well dishes. They were treated for 6 h with the indicated dilutions of the various cytokines. Subsequently, the culture medium was removed, and the cells were lysed in 100 ml lysis buffer (Promega, Madison, WI). Samples of the lysate were used for measuring luciferase activity using a kit (Promega) as recommended by the manufacturer.
Antisera
The rabbit antiserum against ChIFN-a has been described previously. (2, 5) The rabbit antiserum to ChIFN-b was produced by repeated intramuscular (i.m.) injections of purified, bacterially produced ChIFN-b emulsified in Freund's complete (first immunization) or incomplete (subsequent immunizations) adjuvant. Both antisera were used individually at 0.5% or in combination at 0.5% each. Preimmune sera used at the same concentrations served as negative controls.
RESULTS
An alternative bioassay for ChIFN
IFN activity is traditionally determined with antiviral assays in which cytokine-treated cells are analyzed for acquired resistance to infection by a challenge virus. (21) Alternative assays rely on the fact that biologically active IFN triggers a signaling cascade in susceptible cells that causes transcriptional activation of many genes, including Mx. We, therefore, established a quail cell line that carries a luciferase reporter gene controlled by the IFN-stimulated response element (ISRE) of the chicken Mx promoter. (20) The quail cell line CEC-32 was used because previous work demonstrated that it has favorable growth properties and that it responds to ChIFNs with high sensitivity. (2, 5) To determine if this indicator cell line would show the expected IFN response, we exposed the cells for 6 h to various recombinant chicken cytokines. Exposure to IFN-a and IFN-b resulted in approximately 30-fold increased levels of luciferase activity compared with the untreated control (Fig. 1) . IFN-g was also active in this assay, although the luciferase levels were enhanced only about 10-fold. In contrast, treatment of the indicator cell line with a high dose of ChIL-1b did not cause significantly enhanced luciferase levels (Fig. 1) .
Supernatants of human 293T cells transiently transfected with expression plasmids for chicken ChIFN-a or ChIFN-b remained active until diluted at least 1,000,000-fold (Fig. 2, left) , indicating a very high sensitivity of the new bioassay. In repeated experiments, half-maximal luciferase values were obtained with recombinant ChIFN-a (rChIFN-a) that was diluted some 160,000-fold and rChIFN-b that was diluted some (Fig. 2, right) demonstrated that the IFN-a preparation used had a titer of 160,000 U/ml, whereas the titer of the IFNb preparation was about 12,000 U/ml. Thus, IFN-a was detected with comparable sensitivity by both assays, whereas IFN-b was detected about 5-fold better by the Mx-luciferase assay.
Antisera specifically neutralizing either ChIFN-a or ChIFN-b
We previously described a rabbit antiserum that efficiently neutralized ChIFN-a but not ChIFN-b. 
A B
nization of a rabbit with purified rChIFN-b, we also generated an antiserum with high specificity for IFN-b. When used at a final concentration of 0.5%, the IFN-a antiserum reduced the activity of rChIFN-a from transfected human 293T cells by about 60-fold. The IFN-b antiserum was similarly effective against rChIFN-b (Fig. 3) . Importantly, the two antisera showed no measurable cross-reactivity; that is, each antiserum exhibited a very high degree of specificity for the corresponding IFN subtype (Fig. 3) . Virtually identical datasets were obtained with the Mx-luciferase assay (Fig. 3A) and the antiviral assay (Fig. 3B) .
Natural ChIFN-b in supernatants of virus-infected embryo cells
Virus-infected chicken embryo cells are a good source of natural type I IFN. (19) We, therefore, infected these cells with a panel of viruses and assayed the supernatants for IFN activity at 48-72 h postinfection. In order to destroy the inducing virus and to eliminate other activities that might interfere in the IFN assay, the supernatants were subjected to extensive perchloric acid treatment as described. (19) High IFN activity was repeatedly measured in supernatants of cells infected with either NDV, FluA, MVA. In a typical experiment, such supernatants strongly activated the Mx-luciferase construct in our indicator cells if diluted less than approximately 1000-fold (Fig.  4) . In the presence of a 1:1 mixture of IFN-a-specific and IFNb-specific antisera, the IFN activity in the various supernatants was reduced some 60-fold (Fig. 4) , demonstrating that natural virus-induced ChIFN consists mainly of these two IFN subtypes. In the exclusive presence of antiserum to IFN-a, the supernatant from NDV-induced cells lost all its activity (Fig. 4) , indicating that almost no IFN-b was present. In contrast, antiserum to IFN-a alone was rather ineffective on supernatants from cells infected with either influenza A virus or MVA. Inclusion of antiserum to IFN-a alone reduced the activity of these supernatants only about 4-8-fold compared with about 60-fold if both antisera were present (Fig. 4) . In the exclusive presence of antiserum to IFN-b, no significant changes in the IFN activity were recorded. These observations suggested that IFN-a was responsible for about 80% of the IFN activity in the supernatants of cells infected with influenza A virus or MVA. Furthermore, these data unambiguously demonstrated that a small fraction of the IFN activity (20% or less) was due to the presence of IFN-b.
Our results also illustrated clearly that detection of minor IFN subtypes in mixed IFN preparations can be very demanding. The difficulty stems from the fact that the bioassays can- Forty-eight hours later, the supernatants were harvested and treated with acid to destroy virus. IFN composition and titers were determined with the Mx-luciferase assay using the specific antisera as in Figure 3 .
not distinguish between preparations with titer differences of less than 2-fold. Only after the dominant IFN species is neutralized does the activity of the other subtypes become readily detectable. We noted that overall synthesis of IFN and relative amount of IFN-b produced in response to infection with influenza A virus and MVA varied considerably between experiments (data not shown). The reason for this variability is unknown at present. It may be related to the fact that primary chick embryo cells require proper aging in vitro before they respond to external stimuli with vigorous IFN synthesis. (19, 22) 
DISCUSSION
Although chickens possess genes for IFN-a and IFN-b, several previous observations suggested that IFN-b may not contribute significantly to the antiviral defense of chickens. Using conventional IFN titration assays that measure the antiviral activity of the cytokine against VSV, the specific activity of rChIFN-b was found to be about 10-fold lower than that of ChIFN-a. (2) Selective in vivo neutralization of IFN-a with an mAb resulted in enhanced tumor incidence in Rous sarcoma virus-infected chickens. (7) Finally, the application of antisera to IFN-a alone abrogated plasmid DNA transfection-induced antiviral state of chicken embryo cells toward an IFN-sensitive NDV strain. (6) The experiments described in this report were performed to determine if IFN-b is indeed produced under physiologic conditions. By using a nonviral IFN assay, we found that IFN-a and IFN-b exhibit comparable specific activities, arguing against the possibility that the previously observed reduced antiviral activity of rChIFN-b resulted from technical problems associated with the production and purification of this cytokine. Direct evidence that biologically active IFN-b is secreted by virus-infected chicken cells came from experiments in which antisera with high specificity for either IFNa or IFN-b were used. These studies revealed that IFN-a is the dominant virus-induced IFN subtype of chicken embryo cells. They further showed that infection of these cells by some but clearly not all viruses also leads to secretion of detectable levels of IFN-b.
The new Mx-luciferase bioassay we used for measuring IFN activity has several advantages over the conventional antiviral assay. Unlike the antiviral assay, the Mx-luciferase assay detects IFN-a and IFN-b with high sensitivity, it is very fast and can be completed in about 7 h, and it works without infectious agents and can thus be performed in laboratories that lack a permit for work with potentially dangerous viruses. Like the conventional antiviral assay, the Mx-luciferase assay is not specific for type I IFN but responds to IFN-g. This latter property was unexpected because the mammalian Mx genes are preferentially induced by IFN-a and IFN-b. It should be noted that our indicator cells carry a reporter gene that is controlled by an artificially truncated Mx promoter consisting of less than 250 nt of regulatory sequence that contain positive acting elements but might lack some control elements that determine type I IFN specificity. It is also possible that the Mx genes of birds show an intrinsically less restricted response to the various IFN subtypes. The literature contains insufficient data on the regulation of the endogenous Mx gene of the chicken to distinguish between these possibilities.
The antisera we generated by repeated immunization of rabbits with bacterially produced either IFN-a or IFN-b showed a very high degree of specificity for the corresponding IFN subtype. Thus, as in mammals, IFN-a and IFN-b of the chicken are serologically distinct cytokines. This property confirms the validity of the recently introduced nomenclature of ChIFNs in which the nomenclature previously used for mammalian IFNs was applied. (3) The high specificity of the antisera allowed us for the first time to perform a complete analysis of the IFN composition in the medium of virus-infected chicken cells. Our observation that IFN-a was predominantly present in these samples fits nicely with earlier reports that stressed the importance of IFN-a in the antiviral defense of the chicken. It is important to note, however, that the VV and the influenza A virus used in this study also induced good quantities of biologically active IFN-b, whereas NDV (Fig. 4) , Thogoto virus, and Rift valley fever virus (unpublished observations) did not. This contrasts with the situation in mammals in which IFN-b is the dominant type I IFN species produced by virus-infected cells. These subtle differences in gene regulation and the reduced specific antiviral activity toward VSV of chicken IFN-b may be taken as preliminary evidence that IFN-a primarily serves the antiviral defense in chickens. A picture thus emerges in which ChIFNb appears to primarily serve a different as yet undefined physiologic role, such as, for example, promoting the maturation of dendritic cells in response to viral infection. (23) 
